Onpattro intravenous infusion 2mg/mL, from Alnylam Japan, contains patisiran sodium. This concentrate for solution for infusion treats hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis), supplied as 8.8mg 4.4mL 1 bottle with YJ code 1290400A1024.
Onpattro intravenous infusion 2mg/mL
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).